Xcout Intel
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company located in San Diego, California. The company is committed to developing cutting-edge RNA-targeted therapeutics to treat various genetic and severe diseases. ADARx focuses on translating scientific research into life-saving medicines through its proprietary drug discovery pipeline.
Subscribe to see ADARx Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ADARx Pharmaceuticals, Inc. at a glance
ADARx Pharmaceuticals, Inc. is a biotechnology company headquartered in United States. It is publicly listed (ADRX) with a market capitalisation of $1.9B. Xcout tracks 18 named people at ADARx Pharmaceuticals, Inc., including Zhen Li (President & CEO).
ADARx Pharmaceuticals, Inc. leadership
- Zhen LiPresident & CEO
- Ryan FiskChief Financial Officer and Chief Business Officer
- Rui ZhuChief Technology Officer
- Rob AcklesChief People Officer
- Robert A. MacLeodChief Scientific Officer
- Yu ChenFounder and Managing Partner of TCGX
12 more named people on record for ADARx Pharmaceuticals, Inc., with roles, board committees and tenure — see the full roster →
Recent ADARx Pharmaceuticals, Inc. news
- IPOADARx Pharmaceuticals lève 446 millions de dollars lors d'une introduction en bourse augmentée. - fr.qz.com
- IPOIPO registration (S-1)
- IPOADARx Pharmaceuticals Plans IPO of 21.9M Shares at $15-$17 Each
9 corporate events on record, with sources — see the full timeline →
Investors
ADARx Pharmaceuticals, Inc. competitors
A few of ADARx Pharmaceuticals, Inc.'s closest competitors — see the full list of competitors and alternatives →
Adcentrx Therapeutics is a privately held biotechnology company founded in 2021 that focuses on accelerating advanced medical treatments. Its research headquarters are located in San Diego, California.
Adynxx, Inc. is a clinical-stage biopharmaceutical company headquartered in San Francisco, California, focused on biotechnology research and drug development.
DTx Pharma, Inc. is a privately held biotechnology company based in San Diego, California, that addresses the challenges associated with delivering RNA-based therapeutics.
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases.
Iris Medicine is an early-stage life sciences and biotechnology company pioneering allele-selective RNA therapies. Headquartered in California, the company develops novel treatments utilizing its proprietary sbRNA technology platform.
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Get ADARx Pharmaceuticals, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ADARx Pharmaceuticals, Inc. in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 9 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access